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Purpose: This study was conducted to determine whether it is feasible to develop a vein that rhythmically beats by
implanting immature cardiomyocytes in its wall.
Methods: Neonatal cardiomyocytes (5  106 cells each) were transplanted into the wall of the inferior vena cava in six
female Fischer rats; in six rats, only the medium was transplanted. At 3 weeks after transplantation, the grafted site of the
inferior vena cava was exposed and videotaped, and then processed for histology.
Results: Distinct rhythmic beating of the vena cava at the site of cell injection (at a rate lower than aortic beating) was
observed in all six rats treated with neonatal cardiomyocyte injections, but in none of the six that received the medium.
The vena cava continued to beat spontaneously and rhythmically after the aortas were clamped and after the heart was
excised. The beating was manifest by visual contraction and relaxation of the vessel wall. The spontaneous beating rate
was 101 7 beats/min at 1 to 3 minutes after excision of the heart. Hematoxylin and eosin staining showed viable grafts
in the wall of the vena cava in all that were implanted with neonatal cardiac cells; but in none of the vena cava that received
the medium. Neonatal cardiomyocytes in the graft matured with cross striations and stained positive for the muscle
marker sarcomeric actin.
Conclusions: The present study demonstrates that neonatal cardiomyocytes survive, mature, and spontaneously and
rhythmically contract when implanted in the wall of a vein. (J Vasc Surg 2007;45:817-20.)
Clinical Relevance: Venous thrombosis occurs in approximately 0.1% of the general population each year in the United
States. The interaction between vascular endothelium and platelets plays a key role in the thrombotic event. Pulsatility has
been hypothesized to affect the function of vascular endothelium and platelet adhesion. Our present study demonstrates
that engrafted neonatal cardiac cells within the wall of the rat inferior vena cava survive, develop an adult phenotype, and
exhibit spontaneous beating. This model provides a useful experimental approach to investigate the effect of venous
pulsatility on the vascular endothelial behavior in vivo and to determine whether pulsatility prevents platelet adhesion to
endothelium in venous stasis and, ultimately, protects against venous thrombosis.Venous thrombosis occurs in approximately 0.1% of
the general population each year in the United States.1 The
underlying etiologic factors for venous thrombosis involve
Virchow’s triad for thrombogenesis, including vascular
damage to the vein wall,2 venous stasis,3 and hypercoagu-
lability of blood.4 Among the multifactorial etiologies,
venous stasis is important in the thromboembolic process.
Venous thrombosis typically develops in regions of slow
blood flow, for example, in valve cusp pockets. Reduced
blood flow causes stagnant blood pools in which activation
products of the coagulation system accumulate, leading
potentially to local hypercoagulability. The distension of
the vessel walls induced by the pooling of blood can also
result in endothelial cell damage. Rhythmic mechanical
From The Heart Institute, Good Samaritan Hospital, Division of Cardio-
vascular Medicine of the Keck School of Medicine at University of
Southern California.
This work was funded in part by NIH 1R21-HL71965.
Competition of interest: none.
Additional material for this article may be found online at www.jvascsurg.
org.
Reprint requests: Robert A. Kloner, The Heart Institute, Good Samaritan
Hospital, 1225 Wilshire Blvd, Los Angeles, CA 90017 (e-mail: Rkloner@
goodsam.org).
0741-5214/$32.00
Copyright © 2007 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2006.12.013compression has been demonstrated to prevent venous
stasis and venous thrombosis.5
Implantation of cardiac cells around the vein might
serve as a suitable fatigue-resistant power source for venous
compression. We have previously transplanted neonatal
cardiac cells into the wall of the abdominal aorta in rats and
demonstrated that the implanted immature neonatal cardi-
omyocytes survived, matured, developed a blood supply,
and spontaneously contracted and generated measurable
contractile force within the wall of the aorta in rats.6,7
However, whether neonatal cardiomyocytes could even
survive in the environment of a venous wall is unknown. In
this study, we investigated whether neonatal cardiac cells
can survive, mature, and spontaneously contract in the wall
of the inferior vena cava in rats.
MATERIALS AND METHODS
The Association for Assessment and Accreditation of
Laboratory Animal Care International accredits Good Sa-
maritan Hospital. All procedures performed on animals
were approved by the Institutional Animal Care and Use
Committee of Good Samaritan Hospital and were in accor-
dance with the Guide for the Care and Use of Laboratory
Animals (NIH publication No. 85-23, National Academy
Press, Washington DC, revised 1996).
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cardiomyocytes were isolated from the neonatal hearts of
Fischer CDF rats (2 days after birth) and cultured by
previously described methods.8 In brief, after removal of
the atria and great vessels, the ventricles were minced into
small fragments (1 mm3). The minced ventricles were
incubated in digestion buffer containing 100 U/mL colla-
genase and 0.6 mg/mL pancreatin. The isolated cells were
purified by preplating 30 minutes at 37°C to eliminate
attached cells, as previously described.8 The nonattached
cells were plated in culture dishes and cultured in the
presence of 5% carbon dioxide and 95% air at 37°C for 1 to
2 days before transplantation.
Cell transplantation into the wall of the inferior
vena cava. Female Fischer CDF rats were anesthetized
with intraperitoneal ketamine (75 mg/kg) and xylazine (5
mg/kg), and placed in the supine position. The abdominal
area was shaved and prepared for surgery. A midline inci-
sion was made, and the inferior vena cava was exposed after
the intestine was retracted into the right portion of the
abdomen. The site of injection was approximately 3 mm
below the level of the origin of renal veins. The fascia
around the vein was dissected free at this site. The inferior
vena cava was adequately exposed, and neonatal cardio-
myocytes (5  106 cells each) were transplanted into six
rats as described below, and six rats received medium.
Injections were performed with a 28-gauge needle
attached to an insulin syringe under magnification with a
dissecting microscope. Approximately 150 L of base
methylcellulose medium in Iscove modified Dulbecco me-
dia (Stemcell Technologies, Inc, Vancouver, British Co-
lumbia, Canada), with or without cells, was injected di-
rectly into the outer wall of the inferior vena cava and
encompassing its entire circumference to form a cuff. An
even and homogenous grafted cuff containing medium or
cells around the inferior vena cava was formed by using four
injection sites around the circumference: anterior, left lat-
eral, right lateral, and posterior. The posterior injection was
accomplished by twisting the inferior vena cava back to
front. After successful injection, a raised pale bleb extend-
ing 2 to 3 mm along the length of the inferior vena cava and
protruding about 2 mm above the natural surface of the
inferior vena cava was observed. After the injection was
completed, the incision was closed by suturing the muscle
and stapling the skin. Buprenex (0.001 mg/100 g body
weight, twice a day; Reckitt Benckiser Pharma, Richmond,
Va) was given subcutaneously for 2 days as an analgesic
after surgery.
Contractile evaluation. At 3 weeks after surgery, the
rats were anesthetized with ketamine/xylazine and the
inferior vena cava was re-exposed at the site where the cells
(or medium) were implanted. The grafted cuff around the
inferior vena cava was isolated by careful dissection. Hepa-
rin (300 U/kg) was administered intravenously to the rats.
The spontaneous beating of grafted cardiomyocytes was
examined and documented by video camera before and
after the heart was excised. The spontaneous beating rate(beats/min) was counted on the video recording by the
previously described procedures.6
Histologic and immunohistochemical examination.
After contractile evaluation, the inferior vena cava was
removed, washed in 0.9% saline, and fixed in 10% formal-
dehyde for histology. Paraffin-embedded samples were cut
into 5-m sections for hematoxylin and eosin staining and
immunohistochemical staining with primary antibody
against sarcomeric actin (1:75 M0874, Dako, Carpinte-
ria, Calif).
Statistical analysis. All results are presented as
mean  standard error of the mean. Difference between
groups was compared by the Student t test. Statistically
significant difference was established at P  .05.
RESULTS
Contractile potential. Contractile capability was de-
termined before and after the heart was excised at 3 weeks.
The in vivo heart rate assessed by aortic pulsation after
ketamine/xylazine anesthesia was 141  7 beats/min.
Distinct rhythmic beating of the vena cava at the site of cell
injection, at a rate of 92  6 beats/min, was significantly
lower than the rate of aortic beating (P  .002) and was
observed in all six rats injected with neonatal cardiomyo-
cytes but in none of the six animals that received media. The
vena cava continued to beat spontaneously and rhythmi-
cally after the aortas were clamped and the hearts were
excised. The beating was manifest by visual contraction and
relaxation of the vessel wall. The spontaneous beating rate
was 101  7 beats/min at 1 to 3 minutes after excision of
the heart. No significant difference was noted compared
with the rate before heart excision (see video clip, online
only).
Histology. At 3 weeks after surgery, hematoxylin and
eosin staining showed viable grafts around the wall in all six
of the cell-treated inferior vena cavae (Fig 1, A and C) and
in none of the six inferior vena cavae receiving medium (Fig
1, B and D). Neonatal cardiomyocytes in the graft formed
compact, longitudinally oriented cardiac muscle bundles
and mature cross striations (sarcomeres). Most of the
grafted cardiomyocytes were organized into a circular pat-
tern parallel to the vein layers (Fig 1, C). The structure of
the vein wall at the graft site was normal in all samples.
Immunohistochemical staining of the inferior vena
cava for sarcomeric actin was positive in all six cell-treated
inferior vena cavae (Fig 2) and in none of the inferior
vena cava in the medium group after surgery. The stri-
ated cells were easy to identify within the wall of the
inferior vena cava.
DISCUSSION
Our present data demonstrate for the first time, to our
knowledge, that engrafted neonatal cardiac cells around the
outer wall of the rat inferior vena cava survive, develop an
adult phenotype with cross striation, and exhibit spontane-
ous contractions.
In animal studies, cardiac cells have been transplanted
into ears,9 skeletal muscle,10 subcutaneous connective tis-
loose
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aorta.6,7 In 2006, we reported that engrafted cardiomyo-
cytes within the aortic wall generated 0.36 0.05 mm Hg
pulse pressure without pacing; during pacing, the pulse
pressure was 0.78 0.21 mm Hg, with systolic pressure up
to 3.8 mm Hg.7 Our recent unpublished data demon-
strated that cardiomyocytes survived as long as 10 months
Fig 1. Representative hematoxylin and eosin stained sec
that received neonatal heart cells. Viable grafts (black arr
Inferior vena cava in a control rat that received mediu
surrounded by loose connective tissue (A and B, original
boxed area inA. The transplanted cardiomyocytes (black
magnification (400) of the boxed area in B shows the
Fig 2. Immunohistochemical staining of the same slices as in Fig
1, A for sarcomeric actin. The grafted cardiomyocytes are orga-
nized in a circular pattern parallel to the vena cava wall, and show
stronger positive brown staining and typical cross striations of
sarcomere formation (red arrows) (400).within the rat aortic wall and form a circumferential cuffwithin the rat aortic wall. In this study, transplanted cardiac
cells kept a vein rhythmically beating. Thus, as a fatigue-
resistant power source, transplanted cardiac cells have the
potential to provide biologic power for pulsatile motion of
the vein.
One method of prophylaxis against venous stasis and
thrombosis is mechanical external compression, such as
compression stockings13 and intermittent compression de-
vices.14,15 The pulsing venous wall motion induced by
rhythmically contracting transplanted cardiac cells might
be potentially used to prevent vein thrombosis. The rhyth-
mically beating vein may generate pulsatile flow within the
lumen.
Flow conditions can influence the antithrombotic and
prothrombotic responses of vascular endothelium.16 Com-
pared with nonpulsatile flow, pulsatile flow significantly
enhanced saphenous venous endothelial cell nitric oxide
production in a three-dimensional hemodynamically active
model.17 Flow pulsatility may influence the platelet adhe-
sion to endothelium. Jen et al18 demonstrated that platelets
attached on a fibrinogen-coated surface in a tapered flow
chamber were more effectively removed by pulsatile flow
than by equivalent steady flow.
In a clinical study, Naschitz et al19 observed that five
patients with pulsatile venous insufficiency caused by severe
tricuspid regurgitation did not develop venous thrombosis,
phlebitis, or cutaneous ulcers during an average 9.4-year
follow (range, 6 to 15 years). Patients with pulsatile venous
of the abdominal inferior vena cava.A, Inferior vena cava
are located around the inferior vena cava (red arrow). B,
nly. The wall of the inferior vena cava (red arrow) is
ification40). C, Higher magnification (400) of the
s) are visible in the outer wall of the vena cava.D,Higher




arrowinsufficiency had a better clinical course, diminished leuko-
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compared with patients with nonpulsatile venous insuffi-
ciency. These authors suggested that pulsatile shear stress
enhances secretion of cytokines of venous endothelial cells
that prevent a predisposition to platelet aggregation, hyper-
coagulability, and white cell adhesion.
Thus, in theory, the rhythmically beating cardiomyo-
cytes within the vein wall could become a potential power
source for rhythmic contraction of veins to help to prevent
venous thrombosis. This might be relevant to patients who
are immobilized by paralysis, orthopedic procedure, or
disease such as end-stage cancer.
CONCLUSION
This pilot study demonstrated that transplantation of
immature neonatal cardiomyocytes into the wall of a vein
has the potential to cause rhythmic pulsations in the vein
wall. This model provides a useful experimental approach
to investigate the effect of venous pulsatility on the vascular
endothelial behavior in vivo and to determine whether
pulsatility prevents platelet adhesion to endothelium in
venous stasis and protects against vein thrombosis. Fu-
ture studies are needed to measure the strength of con-
traction, diameter reduction, as well as flow velocity in
the beating vein.
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